448 related articles for article (PubMed ID: 18472247)
1. Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children.
Rauchenzauner M; Haberlandt E; Scholl-Bürgi S; Karall D; Schoenherr E; Tatarczyk T; Engl J; Laimer M; Luef G; Ebenbichler CF
Epilepsy Res; 2008 Aug; 80(2-3):142-9. PubMed ID: 18472247
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin and visfatin concentrations in children treated with valproic acid.
Rauchenzauner M; Haberlandt E; Scholl-Bürgi S; Ernst B; Hoppichler F; Karall D; Ebenbichler CF; Rostasy K; Luef G
Epilepsia; 2008 Feb; 49(2):353-7. PubMed ID: 18070089
[TBL] [Abstract][Full Text] [Related]
3. Leptin, leptin soluble receptor and coronary atherosclerosis.
Hoefle G; Saely CH; Risch L; Rein P; Koch L; Schmid F; Aczél S; Marte T; Langer P; Drexel H
Eur J Clin Invest; 2007 Aug; 37(8):629-36. PubMed ID: 17635573
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of allopregnanolone, a neuroactive steroid, and leptin during treatment with valproic acid in children with epilepsy.
Grosso S; Luisi S; Mostardini R; Matera M; Barlocco EG; Casarosa E; Balestri P; Petraglia F
Neuroendocrinology; 2011; 93(3):159-64. PubMed ID: 20980729
[TBL] [Abstract][Full Text] [Related]
5. States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain.
Hamed SA; Fida NM; Hamed EA
Eur J Paediatr Neurol; 2009 May; 13(3):261-8. PubMed ID: 18586538
[TBL] [Abstract][Full Text] [Related]
6. Nutritional and inflammatory status of hemodialysis patients in relation to their body mass index.
Beberashvili I; Sinuani I; Azar A; Yasur H; Feldman L; Efrati S; Averbukh Z; Weissgarten J
J Ren Nutr; 2009 May; 19(3):238-47. PubMed ID: 19243974
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients].
Navarro-Quesada FJ; Lluch-Fernández MD; Vaquero-Abellán M; Marchante-Serrano C; Jiménez C
Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630
[TBL] [Abstract][Full Text] [Related]
8. Leptin, soluble leptin receptors, free leptin index, and their relationship with insulin resistance and BMI: high normal BMI is the threshold for serum leptin increase in humans.
Owecki M; Nikisch E; Miczke A; Pupek-Musialik D; Sowiński J
Horm Metab Res; 2010 Jul; 42(8):585-9. PubMed ID: 20455195
[TBL] [Abstract][Full Text] [Related]
9. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy.
Pylvänen V; Pakarinen A; Knip M; Isojärvi J
Epilepsy Behav; 2006 May; 8(3):643-8. PubMed ID: 16600693
[TBL] [Abstract][Full Text] [Related]
10. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
Hamed SA; Abdella MM
Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
[TBL] [Abstract][Full Text] [Related]
11. Effect of smoking habit on circulating adipokines in diabetic and non-diabetic subjects.
Al Mutairi SS; Mojiminiyi OA; Shihab-Eldeen AA; Al Sharafi A; Abdella N
Ann Nutr Metab; 2008; 52(4):329-34. PubMed ID: 18714151
[TBL] [Abstract][Full Text] [Related]
12. Metabolic alterations during valproic acid treatment: a prospective study.
Abaci A; Saygi M; Yis U; Demir K; Dirik E; Bober E
Pediatr Neurol; 2009 Dec; 41(6):435-9. PubMed ID: 19931165
[TBL] [Abstract][Full Text] [Related]
13. Endocrine effects of valproate in adolescent girls with epilepsy.
de Vries L; Karasik A; Landau Z; Phillip M; Kiviti S; Goldberg-Stern H
Epilepsia; 2007 Mar; 48(3):470-7. PubMed ID: 17326798
[TBL] [Abstract][Full Text] [Related]
14. Increased oxidative stress in epileptic children treated with valproic acid.
Verrotti A; Scardapane A; Franzoni E; Manco R; Chiarelli F
Epilepsy Res; 2008 Feb; 78(2-3):171-7. PubMed ID: 18164182
[TBL] [Abstract][Full Text] [Related]
15. The role of ghrelin in weight gain and growth in epileptic children using valproate.
Gungor S; Yücel G; Akinci A; Tabel Y; Ozerol IH; Yologlu S
J Child Neurol; 2007 Dec; 22(12):1384-8. PubMed ID: 18174556
[TBL] [Abstract][Full Text] [Related]
16. [Twin study on serum leptin and soluble leptin receptor in pubertal girls].
Li HJ; Ji CY; Yang YP; Hu YH
Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Jul; 39(4):245-8. PubMed ID: 16194378
[TBL] [Abstract][Full Text] [Related]
17. Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children.
Rauchenzauner M; Griesmacher A; Tatarczyk T; Haberlandt E; Strasak A; Zimmerhackl LB; Falkensammer G; Luef G; Högler W
Dev Med Child Neurol; 2010 Mar; 52(3):283-8. PubMed ID: 19709134
[TBL] [Abstract][Full Text] [Related]
18. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
[TBL] [Abstract][Full Text] [Related]
19. Effect of sodium valproate monotherapy on serum uric acid concentrations in ambulatory epileptic children: a prospective long-term study.
Attilakos A; Voudris KA; Garoufi A; Mastroyianni S; Dimou S; Prassouli A; Katsarou E
Eur J Paediatr Neurol; 2006; 10(5-6):237-40. PubMed ID: 17035050
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-1, leptin, body composition, and clinical status interactions in children with cystic fibrosis.
Boguszewski MC; Kamoi TO; Bento Radominski R; Boguszewski CL; Rosberg S; Filho NA; Sandrini Neto R; Albertsson-Wikland K
Horm Res; 2007; 67(5):250-6. PubMed ID: 17215581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
